GCIA
SCLN

Gabelli & Co Investment Advisers’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-67,261
Closed -$753K – 199
2017
Q3 		$753K Sell
67,261
-35,000
-34% -$392K 0.09% 91
2017
Q2 		$1.13M Buy
+102,261
New +$1.13M 0.12% 75